MAPT and Alzheimer disease: This sequence was identified through experimental immunization of transgenic mice with mis-disordered tau(151-391/4R) followed by isolation of antibodies and screening for in vitro disruption of tau-tau interaction [4]; tau(294-305) epitope was determined by X-ray crystallography [89] and then tested in an AD-animal model [90].